101714-35-6 Usage
General Description
6-Iodochroman-4-one is a chemical compound falling under the category of organic compounds known as benzopyrans. Benzopyrans are compounds containing a benzene fused to a pyran ring. 6-Iodochroman-4-one is relatively heavy, being composed of several carbon, hydrogen, iodine, and oxygen atoms. The compound is primarily used in scientific research, particularly in the field of organic chemistry, where it may be manipulated and reacted with other chemicals in order to study its properties and potential applications. Notably, its applications in commercial or industrial settings are currently limited due its specialized nature and the complex procedures required to synthesize it.
Check Digit Verification of cas no
The CAS Registry Mumber 101714-35-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,7,1 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 101714-35:
(8*1)+(7*0)+(6*1)+(5*7)+(4*1)+(3*4)+(2*3)+(1*5)=76
76 % 10 = 6
So 101714-35-6 is a valid CAS Registry Number.
101714-35-6Relevant articles and documents
Synthesis of 5-iodobenzofurans and 6-iodobenzopyrans via direct iodination with mercury(II) oxide-iodine reagent
Orito, Kazuhiko,Hatakeyama, Takahiro,Takeo, Mitsuhiro,Suginome, Hiroshi,Tokuda, Masao
, p. 23 - 25 (1997)
A tin(IV) chloride assisted iodo-cyclization of 2-allylphenol gave 2-iodomethyl-2,3-dihydrobenzofuran. A similar cyclization of 2-crotylphenol gave 3-iodo-2-methyl-3,4-dihydro-2H-benzopyran, exclusively. By iodination with mercury(II) oxide-iodine reagent in dichloromethane, 2,3-dihydrobenzofurans or 3,4-dihydro-2H-benzopyrans including the above benzocyclic ethers were easily converted to the corresponding 5- or 6-iodo derivatives, regioselectively, in good yield.
METHODS OF TREATMENT OF AMYLOIDOSIS USING BI-CYCLIC ASPARTYL PROTEASE INHIBITORS
-
Page/Page column 242-243, (2010/02/14)
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
